Evidence map›Paper›PMID 40379608›Full record

ArticleMicrosystems & nanoengineering2025

A wearable self-aid microneedle chip based on actively transdermal delivery of epinephrine.

Chenxi Jin, Peng Guo, Wenjun Li, Wangwang Zhu, Chengcheng Li, Jing Ma, Jun Li, Dachao Li, Jing He, Zhihua Pu

Abstract read
In one paragraph

Article in Microsystems & nanoengineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chenxi JinState Key Laboratory of Precision Measurement Technology and Instruments, Tianjin University, 300072, Tianjin, China.
Peng GuoState Key Laboratory of Precision Measurement Technology and Instruments, Tianjin University, 300072, Tianjin, China.
Wenjun LiState Key Laboratory of Precision Measurement Technology and Instruments, Tianjin University, 300072, Tianjin, China.
Wangwang ZhuState Key Laboratory of Precision Measurement Technology and Instruments, Tianjin University, 300072, Tianjin, China.
Chengcheng LiState Key Laboratory of Precision Measurement Technology and Instruments, Tianjin University, 300072, Tianjin, China.
Jing MaThe Second Medical Center of Chinese PLA General Hospital, 100853, Beijing, China.
Jun LiLang Zhong People's Hospital, 634700, Sichuan, China.
Dachao LiState Key Laboratory of Precision Measurement Technology and Instruments, Tianjin University, 300072, Tianjin, China.
Jing HeThe Second Medical Center of Chinese PLA General Hospital, 100853, Beijing, China. maoxionghj@126.com.
Zhihua PuState Key Laboratory of Precision Measurement Technology and Instruments, Tianjin University, 300072, Tianjin, China. puzhihua@tju.edu.cn.ORCID http://orcid.org/0000-0002-6309-8186

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82072012National Natural Science Foundation of China (National Science Foundation of China) 82102230
6 · The paper itself

Abstract

Epinephrine is important for first aid and usually applied via injection, which is painful and problematic in operation, thereby making it difficult to self-delivery. In this study, a method to actively transdermal delivery of epinephrine is proposed based on incorporating microneedles with iontophoresis, and then a wearable device is fabricated for rapid and controllable self-delivery of epinephrine. The device consists of a hydrogel microneedle array, a conductive drug delivery hydrogel, iontophoresis electrodes, and an encapsulated cartridge with a spring and self-locking micro-mechanism. The microneedles create subcutaneous microchannels, allowing the epinephrine contained in the hydrogel to enter the body under the control of iontophoretic currents. The dosage and rate can be adjusted at different levels by pressing the button so that it can be used by different groups of people for rapid self-aid and recovery from fatigue. The device can be worn in advance if required. In-vitro tests showed that the transdermal delivery rate of the device was between 0.02642 and 0.1059 mg/h cm². As a proof-of-concept application, in-vivo experiments showed that the device could reverse life-threatening shock reactions in a piglet model of hemorrhagic shock through the delivery of epinephrine.

Identifiers

PMID40379608
PMCPMC12084290

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.